Compare IMMR & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMR | KRMD |
|---|---|---|
| Founded | 1993 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.8M | 192.5M |
| IPO Year | 1999 | 2019 |
| Metric | IMMR | KRMD |
|---|---|---|
| Price | $7.57 | $4.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $13.50 | $6.50 |
| AVG Volume (30 Days) | ★ 513.2K | 126.2K |
| Earning Date | 04-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.11% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 0.14 | N/A |
| Revenue | $35,013,000.00 | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $326.00 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $5.25 | $3.20 |
| 52 Week High | $7.50 | $6.61 |
| Indicator | IMMR | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 68.37 | 46.56 |
| Support Level | $6.31 | $3.86 |
| Resistance Level | N/A | $4.26 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 85.61 | 34.45 |
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.